← Back to home
Comparison · Analytics

DoseFinding vs nanoparquet

A side-by-side editorial comparison of DoseFinding and nanoparquet — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs nanoparquet: at a glance

FeatureDoseFindingnanoparquet
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averagingparquet, r-language, interoperability, data-formats
Last editorial update44m ago1h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is nanoparquet?

nanoparquet is chasing byte-level agreement with the Java and Rust Parquet readers, not feature count.

nanoparquet reads and writes Parquet from R with no Arrow dependency, which is its entire reason to exist. The 0.4.0 line renamed the reader API and added schema authoring plus `append_parquet()`, and the 0.5.x releases have gone after interoperability: definition and repetition level encodings the Apache Parquet Java library expects, flatbuffer alignment the Rust arrow-rs reader expects, 128-bit decimals, and Polars-written files that omit the dictionary page offset. The newest release adds `bit64::integer64` columns and writing to stdout.

Read the full nanoparquet trajectory →

DoseFinding vs nanoparquet: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

N
nanoparquet
ANALYTICS
0.0

nanoparquet is chasing byte-level agreement with the Java and Rust Parquet readers, not feature count.

◆ Current state

nanoparquet reads and writes Parquet from R with no Arrow dependency, which is its entire reason to exist. The 0.4.0 line renamed the reader API and added schema authoring plus `append_parquet()`, and the 0.5.x releases have gone after interoperability: definition and repetition level encodings the Apache Parquet Java library expects, flatbuffer alignment the Rust arrow-rs reader expects, 128-bit decimals, and Polars-written files that omit the dictionary page offset. The newest release adds `bit64::integer64` columns and writing to stdout.

◆ Where it's heading

Almost every entry since 0.4.0 names another engine — Java, arrow-rs, Polars, Arrow schema metadata — which tells you the maintainers are treating cross-reader fidelity as the product rather than R-side ergonomics. The type system is filling in from the edges: DECIMAL beyond 8 bytes, UUID, FLOAT16 and INTERVAL as raw lists, and now 64-bit integers with an explicit read-type option instead of a silent cast to double. Writing to `:stdout:` points at a second audience, shell pipelines rather than interactive R.

◆ Prediction

The remaining unmapped Parquet types the changelog has been parking in raw-vector lists — FLOAT16 and INTERVAL — are the obvious next targets, following the same pattern by which DECIMAL and UUID graduated to real R types.

Alternatives to DoseFinding and nanoparquet

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or nanoparquet.

See all DoseFinding alternatives → · See all nanoparquet alternatives →

Recent activity from DoseFinding and nanoparquet

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 3mo agonanoparquet64-bit integer columns and writing Parquet to stdout
  2. 4mo agonanoparquetFiles now readable by the Java and Rust Parquet libraries
  3. 1y agoDoseFindingConditional and predictive power for interim analyses
  4. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  5. 1y agonanoparquetReads Polars files that omit the dictionary page offset
  6. 1y agonanoparquetDate, FLOAT, and mixed-encoding read fixes
  7. 1y agonanoparquetSchema authoring and append_parquet arrive with a renamed API
  8. 1y agonanoparquetFixes a write_parquet crash
  9. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  10. 2y agoDoseFindingCompliance update for R-devel
  11. 3y agoDoseFindingpowMCTBinCount bug fix

Frequently asked questions

What is the difference between DoseFinding and nanoparquet?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and nanoparquet are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than nanoparquet?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and nanoparquet are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to nanoparquet?

Top nanoparquet alternatives in Analytics are ranked by recent ship velocity. Browse the "nanoparquet alternatives" section above for the current picks, or visit /alternatives/nanoparquet for the full list with editorial commentary on each.